Drug profile · INN
methylnaltrexone
RELISTOR
methylnaltrexone (RELISTOR) is a mu opioid receptor antagonist.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — methylnaltrexone
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
methylnaltrexone (RELISTOR) is a mu opioid receptor antagonist.
Key facts
INN methylnaltrexone
Brand RELISTOR
Mechanism Mu opioid receptor antagonist
Mechanism of action
Mu opioid receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is methylnaltrexone?
methylnaltrexone (RELISTOR) is a mu opioid receptor antagonist.
What is the brand name for methylnaltrexone?
RELISTOR is a marketed brand name for methylnaltrexone. Check FDA Drugs@FDA for the current US label holder and prescribing information.